A STAT Investigation

A STAT Investigation Nicholas Florko

DEATH SENTENCE: An 8-part investigation into prisons’ refusal to treat hepatitis C

A STAT Investigation Nicholas Florko

Getting hepatitis C treatment opens new doors for the incarcerated

A STAT Investigation Nicholas Florko

For families, grieving an incarcerated person’s death adds complexity to an already painful process

A STAT Investigation Nicholas Florko

With little more than a typewriter, an Idaho man overturns the entire state’s policy on hepatitis C treatment in prison

A STAT Investigation Nicholas Florko

Despite federal disclosure rules, state prisons hide information on hepatitis C-related deaths

A STAT Investigation Nicholas Florko

Prisons say they can’t afford to cure everyone with hepatitis C. But some are figuring out a way

A STAT Investigation Nicholas Florko

Legal and medical experts say denying hepatitis C care is cruel and unusual punishment, but the courts are still catching up

A STAT Investigation Nicholas Florko

These 8 states are doing the worst job of treating hepatitis C in prisons

A STAT Investigation Nicholas Florko

Hundreds of incarcerated people are dying of hep C — even though we have a simple cure

A STAT Investigation Katie Palmer — STAT and Todd Feathers and Simon Fondrie-Teitler — The Markup

STAT Plus: ‘Out of control’: Dozens of telehealth startups sent sensitive health information to big tech companies

A STAT Investigation Jason Mast

STAT Plus: Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups

A STAT Investigation Lev Facher, Kate Sheridan, and Ed Silverman

STAT Plus: Documents detail how pharmacy giants Walgreens, CVS, and Walmart failed patients in the opioid crisis

A STAT Investigation Nicholas Florko

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

A STAT Investigation Nicholas Florko and Elissa Welle

The FDA stands by as the vaping industry flouts its orders

A STAT Investigation Tara Bannow

STAT Plus: The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy

A STAT Investigation Tara Bannow

Parents and clinicians say private equity’s profit fixation is short-changing kids with autism

A STAT Investigation Allison DeAngelis, Adam Feuerstein, and Jason Mast

STAT Plus: At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say

A STAT Investigation Jared Whitlock

Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation

A STAT Investigation Casey Ross

STAT Plus: Internal documents show privacy lapses at a data powerhouse that holds health records and consumer information on millions of Americans

A STAT Investigation Olivia Goldhill

Encouraged by right-wing doctor groups, desperate patients turn to ivermectin for long Covid

A STAT Investigation Katie Palmer

STAT Plus: Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

A STAT Investigation Usha Lee McFarling

What will it take to level the playing field for Black residents?

A STAT Investigation Usha Lee McFarling

‘It was stolen from me’: Black doctors are forced out of training programs at far higher rates than white residents

A STAT Investigation Casey Ross

STAT Plus: How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

A STAT Investigation Olivia Goldhill

A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens

A STAT Investigation Katie Palmer and Mario Aguilar

STAT Plus: FDA’s breakthrough device program, meant to benefit patients, is delivering the biggest gains for companies

A STAT Investigation Casey Ross

STAT Plus: AI gone astray: How subtle shifts in patient data send popular algorithms reeling, undermining patient safety

A STAT Investigation Hyacinth Empinado and Usha Lee McFarling

A rebel with a cause: As a mentor and a leader, this Black orthopedic surgeon fights to diversify his field

A STAT Investigation Usha Lee McFarling

Orthopedic surgeons pride themselves on fixing things. Can they fix their own field’s lack of diversity?